

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.32370674 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.60078651 |
| 3 | regulation of platelet aggregation (GO:0090330) | 5.43807898 |
| 4 | regulation of platelet activation (GO:0010543) | 5.02663482 |
| 5 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.68230979 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51589105 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 4.42684604 |
| 8 | negative regulation of platelet activation (GO:0010544) | 4.32237771 |
| 9 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.24171206 |
| 10 | positive regulation of receptor recycling (GO:0001921) | 4.22781982 |
| 11 | tolerance induction (GO:0002507) | 4.20352912 |
| 12 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.15813606 |
| 13 | definitive hemopoiesis (GO:0060216) | 4.14696408 |
| 14 | * platelet aggregation (GO:0070527) | 4.14015253 |
| 15 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.10351276 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08301888 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08301888 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01432603 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 3.89267516 |
| 20 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.86142509 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74490783 |
| 22 | positive regulation of blood coagulation (GO:0030194) | 3.73269822 |
| 23 | positive regulation of hemostasis (GO:1900048) | 3.73269822 |
| 24 | negative regulation of focal adhesion assembly (GO:0051895) | 3.69859119 |
| 25 | negative regulation of cell junction assembly (GO:1901889) | 3.69859119 |
| 26 | negative regulation of adherens junction organization (GO:1903392) | 3.69859119 |
| 27 | response to interleukin-15 (GO:0070672) | 3.69047553 |
| 28 | neutrophil activation (GO:0042119) | 3.68162287 |
| 29 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.67298647 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57196732 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.55254685 |
| 32 | * platelet degranulation (GO:0002576) | 3.53789205 |
| 33 | negative T cell selection (GO:0043383) | 3.52189271 |
| 34 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.47824287 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47748084 |
| 36 | leukocyte aggregation (GO:0070486) | 3.46467886 |
| 37 | positive regulation of coagulation (GO:0050820) | 3.45018944 |
| 38 | granulocyte activation (GO:0036230) | 3.40850026 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39294170 |
| 40 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.36143891 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.35195644 |
| 42 | negative regulation of B cell proliferation (GO:0030889) | 3.33958942 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.32452425 |
| 44 | * platelet activation (GO:0030168) | 3.29366915 |
| 45 | hepatocyte apoptotic process (GO:0097284) | 3.28894907 |
| 46 | endothelium development (GO:0003158) | 3.26450154 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.25484292 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.25484292 |
| 49 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.24561401 |
| 50 | megakaryocyte development (GO:0035855) | 3.24188727 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22887984 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18948252 |
| 53 | thymic T cell selection (GO:0045061) | 3.18231835 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.13988027 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 3.12969551 |
| 56 | hypotonic response (GO:0006971) | 3.10672100 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.10420550 |
| 58 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.10211276 |
| 59 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.10206023 |
| 60 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08153433 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08153433 |
| 62 | phagocytosis, engulfment (GO:0006911) | 3.04472530 |
| 63 | platelet formation (GO:0030220) | 3.02665469 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.02658502 |
| 65 | * homotypic cell-cell adhesion (GO:0034109) | 3.02150350 |
| 66 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.01961939 |
| 67 | regulation of endothelial cell differentiation (GO:0045601) | 2.97817150 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97349684 |
| 69 | embryonic hemopoiesis (GO:0035162) | 2.93875963 |
| 70 | protein neddylation (GO:0045116) | 2.93228981 |
| 71 | regulation of hemostasis (GO:1900046) | 2.93186344 |
| 72 | regulation of blood coagulation (GO:0030193) | 2.93186344 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.92149535 |
| 74 | interferon-gamma production (GO:0032609) | 2.91093641 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91081433 |
| 76 | positive regulation of macrophage differentiation (GO:0045651) | 2.89833184 |
| 77 | T cell selection (GO:0045058) | 2.89649488 |
| 78 | negative regulation of stress fiber assembly (GO:0051497) | 2.89294860 |
| 79 | negative regulation of norepinephrine secretion (GO:0010700) | 2.87151456 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87041231 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86188281 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85875379 |
| 83 | negative regulation of interleukin-17 production (GO:0032700) | 2.85108268 |
| 84 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84785751 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 2.84454513 |
| 86 | peptide catabolic process (GO:0043171) | 2.83157510 |
| 87 | blood vessel maturation (GO:0001955) | 2.81856126 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.79599953 |
| 89 | positive regulation of immune response to tumor cell (GO:0002839) | 2.77328858 |
| 90 | regulation of immune response to tumor cell (GO:0002837) | 2.77328858 |
| 91 | regulation of response to tumor cell (GO:0002834) | 2.77328858 |
| 92 | positive regulation of response to tumor cell (GO:0002836) | 2.77328858 |
| 93 | * angiogenesis involved in wound healing (GO:0060055) | 2.76849343 |
| 94 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75783189 |
| 95 | regulation of coagulation (GO:0050818) | 2.74998098 |
| 96 | negative regulation of bone resorption (GO:0045779) | 2.73007880 |
| 97 | leukocyte cell-cell adhesion (GO:0007159) | 2.72871583 |
| 98 | regulation of granulocyte differentiation (GO:0030852) | 2.72511184 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 2.72509435 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.72509435 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.72509435 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.72509435 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 2.72509435 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.72509435 |
| 105 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72482425 |
| 106 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.72242335 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.72230249 |
| 108 | fibrinolysis (GO:0042730) | 2.71200478 |
| 109 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.70143394 |
| 110 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69154249 |
| 111 | regulation of B cell differentiation (GO:0045577) | 2.68839816 |
| 112 | positive regulation of tolerance induction (GO:0002645) | 2.67651996 |
| 113 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.67480122 |
| 114 | positive regulation of B cell mediated immunity (GO:0002714) | 2.67480122 |
| 115 | regulation of early endosome to late endosome transport (GO:2000641) | 2.67290414 |
| 116 | positive T cell selection (GO:0043368) | 2.66598553 |
| 117 | lymphocyte costimulation (GO:0031294) | 2.66291428 |
| 118 | lipoxygenase pathway (GO:0019372) | 2.65085215 |
| 119 | microglial cell activation (GO:0001774) | 2.64955148 |
| 120 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.62980056 |
| 121 | germ cell migration (GO:0008354) | 2.62618463 |
| 122 | regulation of receptor recycling (GO:0001919) | 2.62470073 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 2.62464029 |
| 124 | T cell costimulation (GO:0031295) | 2.62317977 |
| 125 | negative regulation of phagocytosis (GO:0050765) | 2.61525984 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.61358662 |
| 127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61006296 |
| 128 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.60750497 |
| 129 | myeloid cell activation involved in immune response (GO:0002275) | 2.60689262 |
| 130 | extracellular fibril organization (GO:0043206) | 2.60314736 |
| 131 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.58874017 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57557881 |
| 133 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.55846505 |
| 134 | positive regulation of wound healing (GO:0090303) | 2.55774958 |
| 135 | membrane invagination (GO:0010324) | 2.55644399 |
| 136 | regulation of B cell proliferation (GO:0030888) | 2.55634652 |
| 137 | positive regulation of cell junction assembly (GO:1901890) | 2.55516782 |
| 138 | positive regulation of focal adhesion assembly (GO:0051894) | 2.55516782 |
| 139 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.54002763 |
| 140 | stress fiber assembly (GO:0043149) | 2.53272304 |
| 141 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52719788 |
| 142 | fibril organization (GO:0097435) | 2.52406599 |
| 143 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.52272793 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.51163380 |
| 145 | T cell migration (GO:0072678) | 2.51023885 |
| 146 | regulation of cell-substrate junction assembly (GO:0090109) | 2.50370214 |
| 147 | regulation of focal adhesion assembly (GO:0051893) | 2.50370214 |
| 148 | response to peptidoglycan (GO:0032494) | 2.49306417 |
| 149 | negative regulation of blood coagulation (GO:0030195) | 2.48868226 |
| 150 | negative regulation of hemostasis (GO:1900047) | 2.48868226 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.47731943 |
| 152 | positive regulation of mast cell degranulation (GO:0043306) | 2.47731943 |
| 153 | T cell receptor signaling pathway (GO:0050852) | 2.47286146 |
| 154 | mature B cell differentiation involved in immune response (GO:0002313) | 2.47194921 |
| 155 | response to laminar fluid shear stress (GO:0034616) | 2.45086045 |
| 156 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.44587690 |
| 157 | growth hormone receptor signaling pathway (GO:0060396) | 2.44557031 |
| 158 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44553169 |
| 159 | response to protozoan (GO:0001562) | 2.43645666 |
| 160 | mature B cell differentiation (GO:0002335) | 2.43562261 |
| 161 | establishment of endothelial barrier (GO:0061028) | 2.43435889 |
| 162 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.42082102 |
| 163 | trophoblast giant cell differentiation (GO:0060707) | 2.40660283 |
| 164 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.39271139 |
| 165 | myeloid dendritic cell activation (GO:0001773) | 2.38751831 |
| 166 | positive regulation of histone deacetylation (GO:0031065) | 2.35939595 |
| 167 | regulation of tolerance induction (GO:0002643) | 2.35660183 |
| 168 | regulation of erythrocyte differentiation (GO:0045646) | 2.34732907 |
| 169 | lymphocyte homeostasis (GO:0002260) | 2.34013426 |
| 170 | morphogenesis of an endothelium (GO:0003159) | 2.33504277 |
| 171 | endothelial tube morphogenesis (GO:0061154) | 2.33504277 |
| 172 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.32857097 |
| 173 | lymph node development (GO:0048535) | 2.32820642 |
| 174 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.32780521 |
| 175 | regulation of regulatory T cell differentiation (GO:0045589) | 2.31725071 |
| 176 | positive regulation of isotype switching (GO:0045830) | 2.31645117 |
| 177 | pinocytosis (GO:0006907) | 2.31383909 |
| 178 | cellular extravasation (GO:0045123) | 2.30498948 |
| 179 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29681676 |
| 180 | myeloid dendritic cell differentiation (GO:0043011) | 2.29470559 |
| 181 | leukocyte tethering or rolling (GO:0050901) | 2.29075131 |
| 182 | regulation of interferon-alpha production (GO:0032647) | 2.27764088 |
| 183 | cell adhesion mediated by integrin (GO:0033627) | 2.27678792 |
| 184 | actin nucleation (GO:0045010) | 2.24701063 |
| 185 | negative regulation of bone remodeling (GO:0046851) | 2.23720088 |
| 186 | T cell homeostasis (GO:0043029) | 2.23182884 |
| 187 | B cell homeostasis (GO:0001782) | 2.22112112 |
| 188 | progesterone metabolic process (GO:0042448) | 2.21757938 |
| 189 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.20361421 |
| 190 | regulation of integrin activation (GO:0033623) | 2.19881974 |
| 191 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.19528708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.50846794 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.00922688 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.75826530 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.53739284 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31934854 |
| 6 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.27792651 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17359924 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14347115 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97290567 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.96684038 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.90486262 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85477268 |
| 13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.49062144 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43243305 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.40884893 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.39756484 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36828673 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33839852 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.33738634 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28372884 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25605961 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25036188 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22443913 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18252775 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14589994 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.13489215 |
| 27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03920150 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03693861 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01387461 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01354311 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96879639 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89852855 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87579182 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86714773 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.82616966 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.80745850 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78803843 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78308488 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77653652 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75558407 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75369109 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.74927190 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74787815 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71868320 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69765293 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.68430246 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67921951 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66699801 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66321409 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63639830 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63022370 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62692462 |
| 53 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62249647 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60607906 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52687559 |
| 56 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.51590713 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49868390 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44886693 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42665679 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.39474138 |
| 61 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37358968 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36682230 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35233225 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34924621 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34782134 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34572370 |
| 67 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33370528 |
| 68 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32705227 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32162091 |
| 70 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.32112046 |
| 71 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30378252 |
| 72 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30224666 |
| 73 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29432980 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29415731 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28602449 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27738579 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27709727 |
| 78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24010557 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23578527 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21610380 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20176382 |
| 82 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19716817 |
| 83 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17056207 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16783222 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15324463 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14754136 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14080511 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14080511 |
| 89 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.12528938 |
| 90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12416789 |
| 91 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12405013 |
| 92 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12132838 |
| 93 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11554252 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10686294 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10686294 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07171077 |
| 97 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06872057 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06263135 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05534192 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05488326 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03918509 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03055712 |
| 103 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01595324 |
| 104 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00459939 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00154022 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98605264 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98262278 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98038205 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97117053 |
| 110 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96733103 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95756073 |
| 112 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94358778 |
| 113 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93533535 |
| 114 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93365500 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93316910 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93231711 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89075995 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89045759 |
| 119 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88939253 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88858553 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88640334 |
| 122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88343811 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88320433 |
| 124 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86605617 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81465629 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80950009 |
| 127 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78275248 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76831516 |
| 129 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76289953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.61506797 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.01612936 |
| 3 | MP0005671_abnormal_response_to | 2.81663823 |
| 4 | MP0003303_peritoneal_inflammation | 2.73766374 |
| 5 | MP0006054_spinal_hemorrhage | 2.58933589 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.53062430 |
| 7 | MP0004808_abnormal_hematopoietic_stem | 2.42978136 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.32743635 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.27171497 |
| 10 | MP0001800_abnormal_humoral_immune | 2.20408567 |
| 11 | * MP0005464_abnormal_platelet_physiology | 2.19596136 |
| 12 | MP0003279_aneurysm | 2.18383157 |
| 13 | MP0000685_abnormal_immune_system | 2.13493714 |
| 14 | MP0005387_immune_system_phenotype | 2.11790091 |
| 15 | MP0001790_abnormal_immune_system | 2.11790091 |
| 16 | MP0009278_abnormal_bone_marrow | 2.01245154 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.00268585 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.99335359 |
| 19 | * MP0002452_abnormal_antigen_presenting | 1.97410753 |
| 20 | * MP0002398_abnormal_bone_marrow | 1.93852448 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.92435617 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.91888277 |
| 23 | MP0003436_decreased_susceptibility_to | 1.89713016 |
| 24 | MP0002723_abnormal_immune_serum | 1.86059729 |
| 25 | MP0003724_increased_susceptibility_to | 1.85940669 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 1.85786268 |
| 27 | * MP0001819_abnormal_immune_cell | 1.84571874 |
| 28 | * MP0003566_abnormal_cell_adhesion | 1.83977361 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.81719906 |
| 30 | MP0001873_stomach_inflammation | 1.80593426 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.80476794 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78433892 |
| 33 | MP0009785_altered_susceptibility_to | 1.75165485 |
| 34 | MP0005409_darkened_coat_color | 1.73838943 |
| 35 | MP0005025_abnormal_response_to | 1.70923450 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.70212364 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.70212364 |
| 38 | MP0002933_joint_inflammation | 1.67575637 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.67089907 |
| 40 | * MP0005023_abnormal_wound_healing | 1.66782916 |
| 41 | * MP0002419_abnormal_innate_immunity | 1.66543384 |
| 42 | MP0006082_CNS_inflammation | 1.64408642 |
| 43 | MP0005171_absent_coat_pigmentation | 1.60998948 |
| 44 | * MP0000716_abnormal_immune_system | 1.60994805 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.59480836 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.59233458 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.57626366 |
| 48 | * MP0002722_abnormal_immune_system | 1.57538993 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.55117175 |
| 50 | * MP0000465_gastrointestinal_hemorrhage | 1.52865415 |
| 51 | * MP0000689_abnormal_spleen_morphology | 1.49934945 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.49219532 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.49026606 |
| 54 | MP0005083_abnormal_biliary_tract | 1.46361198 |
| 55 | MP0001853_heart_inflammation | 1.46216569 |
| 56 | MP0000858_altered_metastatic_potential | 1.45842717 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.44964369 |
| 58 | * MP0002429_abnormal_blood_cell | 1.44892243 |
| 59 | * MP0003448_altered_tumor_morphology | 1.40242628 |
| 60 | * MP0004947_skin_inflammation | 1.38675538 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.38492863 |
| 62 | MP0000343_altered_response_to | 1.36768173 |
| 63 | MP0009764_decreased_sensitivity_to | 1.30635003 |
| 64 | * MP0001845_abnormal_inflammatory_respons | 1.29182984 |
| 65 | MP0000490_abnormal_crypts_of | 1.25883698 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.25875443 |
| 67 | MP0003045_fibrosis | 1.25827953 |
| 68 | MP0008260_abnormal_autophagy | 1.25689939 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.21415963 |
| 70 | MP0001958_emphysema | 1.20049642 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.18675344 |
| 72 | MP0004130_abnormal_muscle_cell | 1.18257096 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.17144792 |
| 74 | MP0004272_abnormal_basement_membrane | 1.16460515 |
| 75 | * MP0002998_abnormal_bone_remodeling | 1.14713919 |
| 76 | MP0001851_eye_inflammation | 1.14611772 |
| 77 | MP0004381_abnormal_hair_follicle | 1.13269182 |
| 78 | MP0001879_abnormal_lymphatic_vessel | 1.12333614 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.11613929 |
| 80 | MP0005310_abnormal_salivary_gland | 1.09906710 |
| 81 | MP0002006_tumorigenesis | 1.09878819 |
| 82 | MP0001915_intracranial_hemorrhage | 1.05565417 |
| 83 | MP0003075_altered_response_to | 1.04455461 |
| 84 | MP0005058_abnormal_lysosome_morphology | 1.04084869 |
| 85 | * MP0003091_abnormal_cell_migration | 1.03869739 |
| 86 | MP0001663_abnormal_digestive_system | 1.03528157 |
| 87 | * MP0009763_increased_sensitivity_to | 1.03025435 |
| 88 | * MP0000249_abnormal_blood_vessel | 1.01989091 |
| 89 | MP0001849_ear_inflammation | 1.01295206 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.01259852 |
| 91 | MP0006138_congestive_heart_failure | 0.99072755 |
| 92 | MP0001542_abnormal_bone_strength | 0.97544402 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.97059139 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.95988342 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.94628908 |
| 96 | * MP0002086_abnormal_extraembryonic_tissu | 0.93030378 |
| 97 | MP0005390_skeleton_phenotype | 0.92708840 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.92039076 |
| 99 | MP0003866_abnormal_defecation | 0.88594788 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.87633930 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.87216741 |
| 102 | MP0000733_abnormal_muscle_development | 0.87162066 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.86310166 |
| 104 | * MP0002128_abnormal_blood_circulation | 0.85758032 |
| 105 | * MP0002925_abnormal_cardiovascular_devel | 0.84915526 |
| 106 | MP0003828_pulmonary_edema | 0.83987649 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.83804929 |
| 108 | MP0002060_abnormal_skin_morphology | 0.82729459 |
| 109 | * MP0003795_abnormal_bone_structure | 0.82704832 |
| 110 | MP0005451_abnormal_body_composition | 0.82603728 |
| 111 | MP0005503_abnormal_tendon_morphology | 0.82443622 |
| 112 | MP0001243_abnormal_dermal_layer | 0.81501600 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.81298250 |
| 114 | * MP0001614_abnormal_blood_vessel | 0.80937519 |
| 115 | MP0010307_abnormal_tumor_latency | 0.79610568 |
| 116 | MP0008874_decreased_physiological_sensi | 0.78331662 |
| 117 | MP0005275_abnormal_skin_tensile | 0.77976126 |
| 118 | MP0005164_abnormal_response_to | 0.75957181 |
| 119 | MP0004883_abnormal_blood_vessel | 0.75143695 |
| 120 | MP0002254_reproductive_system_inflammat | 0.73856298 |
| 121 | MP0005408_hypopigmentation | 0.73768287 |
| 122 | MP0003950_abnormal_plasma_membrane | 0.73573849 |
| 123 | MP0005166_decreased_susceptibility_to | 0.73563509 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.72716570 |
| 125 | * MP0004510_myositis | 0.72549520 |
| 126 | * MP0008469_abnormal_protein_level | 0.71932547 |
| 127 | * MP0003453_abnormal_keratinocyte_physiol | 0.69089070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.38388074 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.13212816 |
| 3 | Optic neuritis (HP:0100653) | 4.13212816 |
| 4 | Orchitis (HP:0100796) | 4.06278714 |
| 5 | Aortic aneurysm (HP:0004942) | 3.91230152 |
| 6 | Conjunctival telangiectasia (HP:0000524) | 3.79984799 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.65515333 |
| 8 | Aortic dissection (HP:0002647) | 3.62533685 |
| 9 | Poikilocytosis (HP:0004447) | 3.58644493 |
| 10 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.48420248 |
| 11 | Spondylolisthesis (HP:0003302) | 3.41362598 |
| 12 | Persistence of primary teeth (HP:0006335) | 3.34248444 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.32565886 |
| 14 | Arterial thrombosis (HP:0004420) | 3.17146745 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.13310619 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.09539142 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.02989337 |
| 18 | Premature rupture of membranes (HP:0001788) | 2.99773653 |
| 19 | Abnormality of the fingertips (HP:0001211) | 2.99502587 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 2.97024731 |
| 21 | IgM deficiency (HP:0002850) | 2.95580185 |
| 22 | Acanthocytosis (HP:0001927) | 2.94596453 |
| 23 | Increased density of long bones (HP:0006392) | 2.92967973 |
| 24 | Myocardial infarction (HP:0001658) | 2.82597255 |
| 25 | * Prolonged bleeding time (HP:0003010) | 2.81598223 |
| 26 | Recurrent bronchitis (HP:0002837) | 2.73954626 |
| 27 | Thrombocytosis (HP:0001894) | 2.71006184 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.70061819 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.69019322 |
| 30 | Polycythemia (HP:0001901) | 2.67946770 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.67855985 |
| 32 | Keratoconjunctivitis (HP:0001096) | 2.66338845 |
| 33 | Absent frontal sinuses (HP:0002688) | 2.61522773 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.59002144 |
| 35 | Cervical subluxation (HP:0003308) | 2.57694369 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.57047337 |
| 37 | Hemoptysis (HP:0002105) | 2.55410600 |
| 38 | Dilatation of the ascending aorta (HP:0005111) | 2.53476876 |
| 39 | T lymphocytopenia (HP:0005403) | 2.51396312 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 2.51222242 |
| 41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51222242 |
| 42 | Recurrent viral infections (HP:0004429) | 2.51212109 |
| 43 | * Epistaxis (HP:0000421) | 2.50794176 |
| 44 | Mitral valve prolapse (HP:0001634) | 2.50693746 |
| 45 | Vasculitis (HP:0002633) | 2.48250168 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.47835163 |
| 47 | Pulmonary embolism (HP:0002204) | 2.44697888 |
| 48 | * Abnormal platelet volume (HP:0011876) | 2.42253371 |
| 49 | * Petechiae (HP:0000967) | 2.40707313 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.37864375 |
| 51 | Arterial tortuosity (HP:0005116) | 2.36947754 |
| 52 | Abnormal pupillary function (HP:0007686) | 2.36711067 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.36381207 |
| 54 | Vascular tortuosity (HP:0004948) | 2.34394486 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.32327700 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.28683851 |
| 57 | Dyschromatopsia (HP:0007641) | 2.28129910 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 2.27888621 |
| 59 | Abnormality of T cells (HP:0002843) | 2.26957934 |
| 60 | Chronic otitis media (HP:0000389) | 2.26526463 |
| 61 | Cellulitis (HP:0100658) | 2.26008651 |
| 62 | Joint hemorrhage (HP:0005261) | 2.25167112 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.24914718 |
| 64 | Chest pain (HP:0100749) | 2.24390029 |
| 65 | Pustule (HP:0200039) | 2.23599071 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22873747 |
| 67 | * Gingival bleeding (HP:0000225) | 2.22655558 |
| 68 | Peritonitis (HP:0002586) | 2.20752940 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 2.19999598 |
| 70 | Acute myeloid leukemia (HP:0004808) | 2.19358656 |
| 71 | Meningitis (HP:0001287) | 2.18431352 |
| 72 | Leukocytosis (HP:0001974) | 2.16376986 |
| 73 | * Abnormal platelet function (HP:0011869) | 2.14099358 |
| 74 | * Impaired platelet aggregation (HP:0003540) | 2.14099358 |
| 75 | Spinal cord lesions (HP:0100561) | 2.10982663 |
| 76 | Syringomyelia (HP:0003396) | 2.10982663 |
| 77 | Hypoplasia of the iris (HP:0007676) | 2.09502408 |
| 78 | * Menorrhagia (HP:0000132) | 2.08754164 |
| 79 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.08014423 |
| 80 | * Increased mean platelet volume (HP:0011877) | 2.06399320 |
| 81 | Gangrene (HP:0100758) | 2.04000280 |
| 82 | Stomatitis (HP:0010280) | 2.01913077 |
| 83 | IgA deficiency (HP:0002720) | 2.01731755 |
| 84 | Upper limb muscle weakness (HP:0003484) | 2.01236472 |
| 85 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.99292800 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 1.99138914 |
| 87 | Aneurysm (HP:0002617) | 1.98905568 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.98277187 |
| 89 | Lymphopenia (HP:0001888) | 1.97595325 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.96932076 |
| 91 | B lymphocytopenia (HP:0010976) | 1.96667578 |
| 92 | Abnormality of B cell number (HP:0010975) | 1.96667578 |
| 93 | Ureteral stenosis (HP:0000071) | 1.95899879 |
| 94 | Encephalitis (HP:0002383) | 1.94739924 |
| 95 | Abnormality of the prostate (HP:0008775) | 1.93984850 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 1.93635796 |
| 97 | Increased IgE level (HP:0003212) | 1.93216282 |
| 98 | Bicuspid aortic valve (HP:0001647) | 1.93162680 |
| 99 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.90449333 |
| 100 | Hyperthyroidism (HP:0000836) | 1.90143615 |
| 101 | Glomerulopathy (HP:0100820) | 1.89771788 |
| 102 | Hematochezia (HP:0002573) | 1.89354863 |
| 103 | Mitral stenosis (HP:0001718) | 1.88850460 |
| 104 | * Bruising susceptibility (HP:0000978) | 1.88512050 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88174754 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87948716 |
| 107 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85433296 |
| 108 | Obstructive lung disease (HP:0006536) | 1.85433296 |
| 109 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.85265885 |
| 110 | Long eyelashes (HP:0000527) | 1.85231738 |
| 111 | Cerebral hemorrhage (HP:0001342) | 1.84889382 |
| 112 | Portal hypertension (HP:0001409) | 1.84809170 |
| 113 | Atrophic scars (HP:0001075) | 1.84719525 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.84700489 |
| 115 | Ureteral obstruction (HP:0006000) | 1.83076673 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82694874 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.81935096 |
| 118 | Joint swelling (HP:0001386) | 1.81809668 |
| 119 | Emphysema (HP:0002097) | 1.81048768 |
| 120 | Panhypogammaglobulinemia (HP:0003139) | 1.79292355 |
| 121 | Severe combined immunodeficiency (HP:0004430) | 1.77895281 |
| 122 | * Purpura (HP:0000979) | 1.77846410 |
| 123 | Papillary thyroid carcinoma (HP:0002895) | 1.77772278 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.77641186 |
| 125 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77517794 |
| 126 | Periodontitis (HP:0000704) | 1.77432388 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.76672906 |
| 128 | Nasal polyposis (HP:0100582) | 1.76331692 |
| 129 | Autoimmune hemolytic anemia (HP:0001890) | 1.76095066 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.75743055 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.75068318 |
| 132 | Mucosal telangiectasiae (HP:0100579) | 1.73267678 |
| 133 | Amaurosis fugax (HP:0100576) | 1.70395196 |
| 134 | Xanthomatosis (HP:0000991) | 1.69500327 |
| 135 | Uterine leiomyosarcoma (HP:0002891) | 1.66428727 |
| 136 | Leiomyosarcoma (HP:0100243) | 1.66428727 |
| 137 | Thrombophlebitis (HP:0004418) | 1.65171877 |
| 138 | Abnormality of the hepatic vasculature (HP:0006707) | 1.65097919 |
| 139 | Cerebral ischemia (HP:0002637) | 1.64966248 |
| 140 | Increased serum ferritin (HP:0003281) | 1.63527833 |
| 141 | Thyroid-stimulating hormone excess (HP:0002925) | 1.63523796 |
| 142 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.63506361 |
| 143 | Distal lower limb muscle weakness (HP:0009053) | 1.63156181 |
| 144 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.60699403 |
| 145 | Lower limb amyotrophy (HP:0007210) | 1.60383645 |
| 146 | Vertigo (HP:0002321) | 1.60289247 |
| 147 | Bladder carcinoma (HP:0002862) | 1.60147985 |
| 148 | Bladder neoplasm (HP:0009725) | 1.60147985 |
| 149 | Paralysis (HP:0003470) | 1.58886305 |
| 150 | Episodic fever (HP:0001954) | 1.58280750 |
| 151 | Ankyloglossia (HP:0010296) | 1.58219834 |
| 152 | Tetraparesis (HP:0002273) | 1.57707770 |
| 153 | Tinnitus (HP:0000360) | 1.56901416 |
| 154 | Abnormality of oral frenula (HP:0000190) | 1.56603115 |
| 155 | Basal ganglia calcification (HP:0002135) | 1.55281784 |
| 156 | Termporal pattern (HP:0011008) | 1.52350647 |
| 157 | Insidious onset (HP:0003587) | 1.52350647 |
| 158 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.52186866 |
| 159 | Fatigue (HP:0012378) | 1.52182623 |
| 160 | Cranial hyperostosis (HP:0004437) | 1.51521380 |
| 161 | Interstitial pulmonary disease (HP:0006530) | 1.50643333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.20132535 |
| 2 | TXK | 4.75372587 |
| 3 | MAP4K1 | 3.46918090 |
| 4 | EEF2K | 3.14296318 |
| 5 | MYLK | 2.65410019 |
| 6 | STK10 | 2.63593467 |
| 7 | TGFBR2 | 2.61156525 |
| 8 | PTK2B | 2.51120251 |
| 9 | JAK3 | 2.35312430 |
| 10 | EPHB1 | 2.17839228 |
| 11 | TRIB3 | 2.10295389 |
| 12 | PKN2 | 2.09229598 |
| 13 | TYK2 | 2.03472207 |
| 14 | FGR | 1.93274052 |
| 15 | EIF2AK1 | 1.87916077 |
| 16 | JAK1 | 1.83884127 |
| 17 | TAOK3 | 1.83590821 |
| 18 | ZAP70 | 1.83379536 |
| 19 | PLK4 | 1.78910069 |
| 20 | BMPR2 | 1.73386698 |
| 21 | ITK | 1.70786512 |
| 22 | LRRK2 | 1.69810023 |
| 23 | BTK | 1.64925201 |
| 24 | CDK12 | 1.64020449 |
| 25 | KIT | 1.60535046 |
| 26 | TEC | 1.54244351 |
| 27 | FGFR3 | 1.48353285 |
| 28 | EPHA3 | 1.45807582 |
| 29 | TRPM7 | 1.44224911 |
| 30 | FGFR4 | 1.39802060 |
| 31 | TTN | 1.32489566 |
| 32 | PIM1 | 1.32467529 |
| 33 | LMTK2 | 1.28795145 |
| 34 | RPS6KA4 | 1.27855861 |
| 35 | RPS6KB2 | 1.27451354 |
| 36 | GRK5 | 1.25762883 |
| 37 | TBK1 | 1.23238302 |
| 38 | MAP3K14 | 1.22890993 |
| 39 | MARK3 | 1.19436646 |
| 40 | MAP2K3 | 1.18097765 |
| 41 | LCK | 1.17576683 |
| 42 | DDR2 | 1.17485476 |
| 43 | ERN1 | 1.14189412 |
| 44 | IKBKE | 1.12862906 |
| 45 | STK3 | 1.11528031 |
| 46 | MAP3K10 | 1.11155351 |
| 47 | KDR | 1.11079484 |
| 48 | DMPK | 1.10577479 |
| 49 | GRK6 | 1.07606280 |
| 50 | TGFBR1 | 1.07126561 |
| 51 | CDK6 | 1.06160656 |
| 52 | TAOK2 | 1.06138142 |
| 53 | PRPF4B | 1.06093937 |
| 54 | * HCK | 1.03689287 |
| 55 | BMX | 1.00555485 |
| 56 | TIE1 | 1.00375673 |
| 57 | PTK6 | 0.98690832 |
| 58 | IRAK1 | 0.96865338 |
| 59 | CSK | 0.96811303 |
| 60 | IKBKB | 0.93694283 |
| 61 | STK24 | 0.93253317 |
| 62 | TSSK6 | 0.91961466 |
| 63 | CDK9 | 0.90277287 |
| 64 | RIPK1 | 0.87624333 |
| 65 | FER | 0.86153052 |
| 66 | ILK | 0.85174569 |
| 67 | IRAK4 | 0.85021829 |
| 68 | SGK3 | 0.84378303 |
| 69 | * SYK | 0.83796296 |
| 70 | YES1 | 0.83556748 |
| 71 | MAP3K1 | 0.81925032 |
| 72 | JAK2 | 0.80246790 |
| 73 | MATK | 0.80119046 |
| 74 | PDGFRB | 0.80066471 |
| 75 | ALK | 0.80044150 |
| 76 | ERBB2 | 0.79511282 |
| 77 | SGK2 | 0.79106622 |
| 78 | PRKD2 | 0.78470887 |
| 79 | PRKCH | 0.77876722 |
| 80 | PAK4 | 0.77606647 |
| 81 | CHUK | 0.77146407 |
| 82 | SIK3 | 0.76987114 |
| 83 | MAP3K5 | 0.76946276 |
| 84 | MAPKAPK3 | 0.76622175 |
| 85 | NLK | 0.76210921 |
| 86 | TAOK1 | 0.76110388 |
| 87 | CSF1R | 0.75838417 |
| 88 | PAK2 | 0.74426187 |
| 89 | CDC42BPA | 0.71524492 |
| 90 | MAP3K2 | 0.71178633 |
| 91 | MAP3K8 | 0.71176696 |
| 92 | BRD4 | 0.70214495 |
| 93 | MARK2 | 0.69992921 |
| 94 | MAP3K13 | 0.69676184 |
| 95 | CAMK1D | 0.69131994 |
| 96 | PAK1 | 0.68855258 |
| 97 | ERBB4 | 0.67010898 |
| 98 | SIK2 | 0.66774351 |
| 99 | MAP3K11 | 0.64842708 |
| 100 | PRKG2 | 0.63703264 |
| 101 | MAPKAPK2 | 0.63328425 |
| 102 | EPHB2 | 0.63296988 |
| 103 | MAPK12 | 0.63194078 |
| 104 | PTK2 | 0.62902345 |
| 105 | TYRO3 | 0.60465813 |
| 106 | LYN | 0.60039650 |
| 107 | CDK4 | 0.59891775 |
| 108 | NEK9 | 0.59246908 |
| 109 | PNCK | 0.57458842 |
| 110 | IRAK3 | 0.56980231 |
| 111 | PRKD1 | 0.56167533 |
| 112 | PDGFRA | 0.55723179 |
| 113 | SIK1 | 0.55682809 |
| 114 | FYN | 0.55582920 |
| 115 | BLK | 0.53960165 |
| 116 | IRAK2 | 0.53181938 |
| 117 | LATS1 | 0.51222039 |
| 118 | NTRK1 | 0.50425343 |
| 119 | NEK2 | 0.49996612 |
| 120 | NME2 | 0.49753122 |
| 121 | ADRBK1 | 0.49409002 |
| 122 | RET | 0.49257807 |
| 123 | PLK2 | 0.49046164 |
| 124 | PIK3CG | 0.48502260 |
| 125 | CLK1 | 0.48308561 |
| 126 | MOS | 0.48062070 |
| 127 | STK4 | 0.47722568 |
| 128 | PRKCQ | 0.47466015 |
| 129 | MAP3K6 | 0.44527928 |
| 130 | DAPK3 | 0.44039128 |
| 131 | MELK | 0.43986753 |
| 132 | MTOR | 0.43470917 |
| 133 | MAP2K1 | 0.43143788 |
| 134 | CAMKK2 | 0.43112289 |
| 135 | RPS6KA6 | 0.42921668 |
| 136 | CAMK1G | 0.42035079 |
| 137 | TNK2 | 0.40017342 |
| 138 | HIPK2 | 0.39320679 |
| 139 | MST4 | 0.36692567 |
| 140 | MAPKAPK5 | 0.34926200 |
| 141 | FES | 0.34411406 |
| 142 | MAP3K3 | 0.34226804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63193862 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.46835684 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41727039 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23033681 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.21280837 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.16489528 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.02844084 |
| 8 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01374009 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01017941 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.95382861 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94756209 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90145200 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80634664 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74454957 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65122159 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63802210 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63238583 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.58762606 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51522346 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.51475006 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48598784 |
| 22 | * Platelet activation_Homo sapiens_hsa04611 | 1.48046963 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.46334160 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.43161513 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42835897 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41917985 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40797771 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40575927 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36238469 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.35791755 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35458530 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34461909 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.32930941 |
| 34 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29470158 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27603986 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.26396052 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25964706 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25536210 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24116395 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24092517 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.23202092 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22058501 |
| 43 | * Focal adhesion_Homo sapiens_hsa04510 | 1.20774202 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19805874 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16213591 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14819095 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09737056 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08042265 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07014959 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07006514 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.03794453 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03628363 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02561415 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.02367194 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02104662 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00527745 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.99469169 |
| 58 | * Phagosome_Homo sapiens_hsa04145 | 0.99294841 |
| 59 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98897707 |
| 60 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97404475 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96796683 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96745070 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96278793 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94296815 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93253251 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.91974136 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91143388 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.90003021 |
| 69 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89380267 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.88945832 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88547705 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87977329 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87690073 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87301953 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86340021 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85139637 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.84919009 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83276730 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82713503 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.81250051 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.77829422 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77629417 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77428641 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74389903 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72755679 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71068717 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70891690 |
| 88 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70344203 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69894475 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69807586 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.69187252 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66813744 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66548819 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.65888706 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.65551611 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.63477471 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61647733 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61368487 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61357083 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61194864 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60976102 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.59844718 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59629130 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59213881 |
| 105 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58493256 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58215297 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.57459745 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57406025 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55161114 |
| 110 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54877853 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53398112 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.53362143 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52766703 |
| 114 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51799379 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51492327 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.51384136 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50716121 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49092341 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.48785035 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.48401085 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44312864 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43197831 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42818818 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40987477 |
| 125 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40284424 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38427038 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37606809 |

